| abstract |
The present invention relates to a compound of formula (I) wherein R 1 to R 5 , A, B, Q, W, and X are defined in the detailed description and claims, and It relates to pharmaceutically acceptable salts and esters. In addition, the present invention relates to methods of making and using compounds of formula (I) and pharmaceutical compositions containing the compounds. The compounds of formula (I) are antagonists of the CRTH2 receptor and may be useful in the treatment of diseases and disorders related to that receptor, such as asthma. |